Hester Biosciences Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|
| Revenue | 77.73 | 64.13 | 74.85 |
| Operating Expense | 62.97 | 53.81 | 58.77 |
| Net Profit | 9.64 | 4.44 | 9.34 |
| Net Profit Margin | 12.40 | 6.92 | 12.48 |
| Earning Per Share | 11.33 | 5.22 | 10.97 |
| EBIDTA | 16.59 | 9.93 | 16 |
| Effective Tax Rate | 24.86 | 16.09 | 19.09 |
| Particulars | Mar 2025 |
|---|---|
| Revenue | 77.73 |
| Operating Expense | 62.97 |
| Net Profit | 9.64 |
| Net Profit Margin | 12.40 |
| Earning Per Share | 11.33 |
| EBIDTA | 16.59 |
| Effective Tax Rate | 24.86 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 285.16 | 254 | 219.35 |
| Operating Expenses Annual | 237.81 | 199.11 | 158.78 |
| Operating Profit Annual | 51.60 | 60.21 | 65.23 |
| Interest Annual | 5.09 | 6.50 | 2.47 |
| Depreciation | 9.78 | 9.79 | 9.50 |
| Net Profit Annual | 27.16 | 32.34 | 39.52 |
| Tax Annual | 9.57 | 11.58 | 13.74 |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 285.16 |
| Operating Expenses Annual | 237.81 |
| Operating Profit Annual | 51.60 |
| Interest Annual | 5.09 |
| Depreciation | 9.78 |
| Net Profit Annual | 27.16 |
| Tax Annual | 9.57 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 4.30 | 1.53 | 1.24 |
| Cash Flow from Operations | 42.81 | 33.36 | 15.91 |
| Cash Flow from Investing | -20.63 | -71.96 | -110.58 |
| Cash Flow from Financing | -24.07 | 41.38 | 94.96 |
| Cash Flow at the End | 2.41 | 4.30 | 1.53 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 4.30 |
| Cash Flow from Operations | 42.81 |
| Cash Flow from Investing | -20.63 |
| Cash Flow from Financing | -24.07 |
| Cash Flow at the End | 2.41 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | 18.10 | 23.70 | 29.74 |
| PBIT Margin (%) | 14.67 | 19.85 | 25.41 |
| PBT Margin (%) | 11.79 | 16.79 | 15.13 |
| Net PROFIT Margin (%) | 9.52 | 12.73 | 18.02 |
| Return On Networth / Equity (%) | 8.98 | 11.53 | 15.62 |
| Return On Networth /Employed (%) | 8.51 | 11.52 | 17.26 |
| Return On Assets (%) | 5.52 | 7.38 | 12.25 |
| Total Debt / Equity (X) | 0.49 | 0.51 | 0.27 |
| Asset Turnover Ratio (%) | 0.58 | 0.58 | 0.68 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | 18.10 |
| PBIT Margin (%) | 14.67 |
| PBT Margin (%) | 11.79 |
| Net PROFIT Margin (%) | 9.52 |
| Return On Networth / Equity (%) | 8.98 |
| Return On Networth /Employed (%) | 8.51 |
| Return On Assets (%) | 5.52 |
| Total Debt / Equity (X) | 0.49 |
| Asset Turnover Ratio (%) | 0.58 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 106.75 | 110.69 | 85.99 |
| Total Current Assets Annual | 204.41 | 216.05 | 166.47 |
| Non Current Assets Annual | 345.13 | 329.77 | 257.97 |
| Total Shareholders Funds Annual | 312.71 | 292.38 | 268.43 |
| Total Assets Annual | 549.55 | 545.82 | 424.44 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 106.75 |
| Total Current Assets Annual | 204.41 |
| Non Current Assets Annual | 345.13 |
| Total Shareholders Funds Annual | 312.71 |
| Total Assets Annual | 549.55 |
EPS (INR)
Expected
1.52
Reported
1.82
Surprise
19.74%
Dec 2024
EPS beaten by 19.74%
Sep 2024
EPS beaten by -2.12%
Jun 2024
EPS beaten by 2.28%
